Design of SARS-CoV-2 RBD mRNA Vaccine Using Novel Ionizable Lipids
U. Elia, R. Srinivas, N. Dammes, E. Bar-Haim, G. S. Naidu, E. Makdasi, O. Cohen, D. Peer
This study designs an mRNA vaccine targeting SARS-CoV-2 RBD using novel ionizable lipids, showing strong immune responses in mice.
bioRxiv · Oct 15, 2020Immunology